文献速递疝与腹壁外科围术期管理与 ERAS

腹股沟疝修补术后新发持续性阿片类药物使用

New Persistent Opioid Use After Inguinal Hernia Repair.
PubMed 文献 · Ann Surg · 2020-10-15

基于2008至2016年全国去标识化行政理赔数据库的回顾性横断面研究,纳入59,795例阿片类未暴露并接受腹股沟疝修补术的患者。

要点

  • 腹股沟疝修补术后新发持续性阿片类使用发生率为1.5%。
  • 术前30天内开具阿片类处方者术后持续使用风险最高(OR 4.34)。
  • 术前阿片类处方52%由外科医生开具、16%由基层医生开具。

核心结论

  • 腹股沟疝修补术后1.5%患者出现新发持续性阿片类使用,术前30天内开具阿片类处方与该并发症关联最强。

研究设计与样本

  • 回顾性横断面研究,使用2008至2016年全国去标识化行政理赔数据库,纳入59,795例阿片类未暴露并接受腹股沟疝修补术且符合纳入标准的患者。
  • 患者平均(SD)年龄57.8(16.1)岁,55,014例(92%)为男性。

主要发现

  • 术前30天内开具阿片类处方与新发持续性阿片类使用关联最强,OR 4.34(95%CI 3.75-5.01)。
  • 其他风险因素包括接受更大剂量阿片类处方、更多合并症、发生重大术后并发症以及某些心理健康障碍和疼痛障碍。
  • 术前阿片类处方52%由外科医生开具,16%由基层医生开具。

临床怎么用

  • 围术期应关注术前30天内阿片类处方史,识别术后持续阿片类使用高风险患者并优化镇痛管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the incidence of new persistent opioid use after inguinal hernia repair as well as its associated risk factors. SUMMARY OF BACKGROUND DATA: The development of new persistent opioid use after surgery is a common complication; however, its incidence following inguinal hernia repair has not been described. Given that roughly 800,000 inguinal hernia repairs are performed annually in the USA, any incidence could have profound implications for patients. METHODS: A retrospective cross-sectional study of the incidence of new persistent opioid use after inguinal hernia repair using a national database of de-identified administrative health claims of opioid-naïve patients undergoing surgery from 2008 to 2016. RESULTS: During the study period, 59,795 opioid-naïve patients underwent inguinal hernia repair and met inclusion criteria. Mean (SD) age was 57.8 (16.1) years and 55,014 (92%) patients were male. Nine hundred twenty-two (1.5%) patients continued filling opioids prescriptions for at least 3 months after surgery. The most significant risk factor for developing new persistent opioid use after surgery was filling an opioid prescription in the 30 days before surgery (odds ratio 4.34, 95% confidence interval 3.75-5.01). These prescriptions were provided by surgeons in 52% of cases and primary care physicians in 16% of cases. Other risk factors for new persistent opioid use included receiving a larger opioid prescription, having more comorbidities, having a major postoperative complication, and certain mental health disorders and pain disorders. CONCLUSIONS: After undergoing inguinal hernia repair, 1.5% of patients developed new persistent opioid use. Filling an opioid prescription in the 30 days before surgery had the strongest association with this complication.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Howard R, Gunaseelan V, Brummett C, et al. New Persistent Opioid Use After Inguinal Hernia Repair. Ann Surg. 2020. PMID: 33065653. doi:10.1097/SLA.0000000000004560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。